® 250 "

: Levetiracetam Teva ® 250 Mg. ?  »
|
-

PER OS

Tablets

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

141 43 31958 01

Teva Pharmaceutical Industries Ltd

08/2014 - 08/2024

.
, .
.
/
Levetiracetam 250 MG
Blister pvdc/aluminium 30 x TABLETS 36
Blister pvdc/aluminium 60 x TABLETS 36

*

*

 

.

 
" !
 

- !
:  »
238
, ,